Evidence map›Paper›PMID 39231278›Full record

ArticleDevelopmental medicine and child neurology2025

Parental diagnostic delay and developmental outcomes in congenital and childhood-onset myotonic dystrophy type 1.

Federica Trucco, Emilio Albamonte, Marika Pane, Federica Ricci, Adele D'amico, Guja Astrea, Isabella Moroni, Antonella Pini, Chiara Fiorillo, Angela Berardinelli and 3 more

Abstract read
In one paragraph

Article in Developmental medicine and child neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. [Two cases of congenital myotonic dystrophy type 1 caused byZhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Federica TruccoNeMO Clinical Center, Fondazione Serena, Milan, Italy.ORCID 0000-0002-1147-0126
Emilio AlbamonteNeMO Clinical Center, Fondazione Serena, Milan, Italy.
Marika PaneCentro Clinico NeMO, Fondazione Policlinico Universitario Agostino Gemelli Istituto di Ricovero e Cura a Carattere Scientifico, Rome, Italy.
Federica RicciDepartment of Sciences of Public Health and Pediatrics, University of Turin, Turin, Italy.ORCID 0000-0003-2019-612X
Adele D'amicoUnit of Muscular and Neurodegenerative Disorders, Bambino Gesù Children's Hospital, Istituto di Ricovero e Cura a Carattere Scientifico, Rome, Italy.
Guja AstreaDepartment of Developmental Neuroscience, Istituto di Ricovero e Cura a Carattere Scientifico Fondazione Stella Maris, Pisa, Italy.
Isabella MoroniDepartment of Pediatric Neurosciences, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Neurologico Carlo Besta, Milan, Italy.
Antonella PiniPediatric Neuromuscular Unit, UOC Neuropsichiatria Dell'Età Pediatrica, Istituto di Ricovero e Cura a Carattere Scientifico Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.
Chiara FiorilloUnit of Child Neuropsychiatry, Istituto di Ricovero e Cura a Carattere Scientifico Istituto Giannina Gaslini and DINOGMI, University of Genova, Genoa, Italy.
Angela BerardinelliChild and Adolescent Neuromuscular Disorder Unit, Istituto di Ricovero e Cura a Carattere Scientifico Mondino Foundation, Pavia, Italy.
Nicholas E JohnsonDepartment of Neurology, Virginia Commonwealth University, Richmond, VA, USA.
Valeria A SansoneNeMO Clinical Center, Fondazione Serena, Milan, Italy.
DM1 Paediatric Working Group

Funding

Identifying the RNA Splicing and Gene Expression Changes that Cause Congenital Myotonic Dystrophy (Renewal)R01NS104010 · NINDS · VIRGINIA COMMONWEALTH UNIVERSITY · PI Nicholas Elwood Johnson · 2018 to 2026
$4.4M
Trial Readiness and Endpoint Assessment in LGMDR1 (TREATing-LGMDR1)U01NS124974 · NINDS · VIRGINIA COMMONWEALTH UNIVERSITY · PI Nicholas Elwood Johnson · 2023 to 2026
$4.0M
Health Endpoints and Longitudinal Progression in Congenital Myotonic Dystrophy (HELP-CDM)K23NS091511 · NINDS · VIRGINIA COMMONWEALTH UNIVERSITY · PI JOHNSON, NICHOLAS ELWOOD · 2015 to 2019
$997k
Development and validation of clinical outcome assessments in LGMD2AR21TR003184 · NCATS · VIRGINIA COMMONWEALTH UNIVERSITY · PI JOHNSON, NICHOLAS ELWOOD, STATLAND, JEFFREY · 2020 to 2021
$452k
FDA HHS R01 FD006071Fondazione Telethon GUP19002NCATS NIH HHS R21 TR003184NCBDD CDC HHS U01 DD001242NINDS NIH HHS K23 NS091511NINDS NIH HHS R01 NS104010NINDS NIH HHS U01 NS124974
6 · The paper itself

Abstract

aimTo investigate the timing of type 1 myotonic dystrophy (DM1) diagnosis in parents of affected children and describe children's perinatal characteristics and developmental outcomes.

methodThis was a descriptive case series of children with congenital myotonic dystrophy (CDM) and childhood-onset myotonic dystrophy (ChDM). Parental timing of DM1 diagnosis and the perinatal, motor, and cognitive outcomes of paediatric patients were recorded.

resultsA total of 139 children followed by 12 highly specialized tertiary care neuromuscular centres in Italy and one tertiary neuromuscular centre in the USA were included: 105 children with CDM and 34 children with ChDM (mean age 8 years 8 months and 12 years 2 months respectively; 49 males and 17 males respectively). Seventy (50%) parents were diagnosed with adult-onset DM1 after the affected child was diagnosed. Only 12 (17%) of the 69 parents known to be affected had prenatal testing. Of the 105 children with CDM, 98% had maternally inherited CDM, 36% were born preterm, 83% required a stay in the neonatal intensive care unit for more than 48 hours, 84% and 79% had ambulation and speech delay, and 84% had an IQ lower than 70. Of the 34 children with ChDM, 59% had paternally inherited ChDM, 91% were born at term, and 36% had an IQ lower than 70.

interpretationDelay in diagnosing DM1 affects family planning. The prenatal and perinatal outcomes of the affected offspring emphasize the need for proactive counselling as parents may be reluctant to conduct prenatal testing.

Indexed as

Delayed DiagnosisDevelopmental DisabilitiesMyotonic DystrophyParentsAdultAge of OnsetChildChild, PreschoolFemaleHumansInfantItalyMale

Identifiers

PMID39231278
PMCPMC11794672

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.